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Abstract: Brugada syndrome and early repolarization syndrome are both classified as J-wave syn-
dromes, with a similar mechanism of arrhythmogenesis and with the same basis for genesis of the
characteristic electrocardiographic features. The Brugada syndrome is now considered a conduction
disorder based on subtle structural abnormalities in the right ventricular outflow tract. Recent
evidence suggests structural substrate in patients with the early repolarization syndrome as well. We
propose a unifying mechanism based on these structural abnormalities explaining both arrhythmoge-
nesis and the electrocardiographic changes. In addition, we speculate that, with increasing technical
advances in imaging techniques and their spatial resolution, these syndromes will be reclassified as
structural heart diseases or cardiomyopathies.
Keywords: arrhythmias; Brugada syndrome; early repolarization pattern; fibrosis; conduction; repo-
larization
1. Introduction
In Brugada syndrome and early repolarization syndrome patients, arrhythmias occur
in the absence of gross structural abnormalities [1]. Both syndromes are characterized by
abnormal deflections at the end or briefly after the QRS complex, which are referred to as
J-waves. Based on these ECG characteristics, Brugada syndrome and early repolarization
syndrome are referred to as J-wave syndromes and thought to share a pathophysiological
mechanism [1–3].
The initially proposed mechanism underlying the Brugada syndrome involved the
existence of regional differences in early repolarization [4]. These differences were initially
described in the transmural plane of small blocks of canine ventricular myocardium, in
which the subepicardial action potentials repolarize first [5]. The latter could set the stage
for “phase-2 reentry” in the presence of a reduced net inward current, a loss-of-function
mutation in the sodium or calcium channels, or by a gain-of-function mutation of the
channel carrying the transient outward current [6]. This mechanism has been challenged
by multiple experimental and clinical studies. These studies have shown that activation in
the right ventricular outflow tract (RVOT) is discontinuous and delayed. This predisposes
to excitation failure, ST-segment elevation, and the onset of reentry [7–12]. These findings
have led to the now-accepted view that abnormal conduction in the RVOT underlies the
Brugada syndrome [13,14]. This classifies the syndrome as a cardiomyopathy rather than a
channelopathy [15]. For the early repolarization syndrome, the current view is still—as
indicated by the name—that the syndrome is caused by enhanced local early repolariza-
tion [1]. However, we have recently shown that in a young patient local conduction delay
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caused by structural abnormalities led to the early repolarization syndrome [16]. Removal
of the region containing the abnormalities cured the syndrome, indicating that abnormal
conduction may be the mechanism causing early repolarization syndrome similar to the
Brugada syndrome.
In this review, we will discuss how abnormal conduction explains the overlap in
arrhythmogenic mechanisms in Brugada syndrome and early repolarization syndrome
and how differences between the syndromes are explained. We speculate that the J-wave
syndromes represent a part of a larger spectrum of cardiomyopathies.
2. Abnormal Conduction in RVOT in Brugada Syndrome
Structural abnormalities caused by interstitial fibrosis play an essential role in the
generation of ST segment elevation and the onset of arrhythmias in Brugada syndrome
patients [10,17–19]. These structural changes lead to a localized branching and converging
myocardial network, very much resembling that of the network of surviving fibers in
infarcted myocardium [8,20]. This may cause activation delay at the branching point
(Figure 1A) and even excitation failure (Figure 1B) when the depolarizing current generated
by the proximal myocardium is too small to activate distal myocardium (current-to-load
mismatch) [21,22]. The ratio of the current generated and the minimum current required
to maintain propagation is referred to as the safety factor for cardiac conduction and is
also referred to as conduction reserve [22–24]. Sodium channel blockade decreases the
safety for conduction and promotes conduction block at branching sites. This effect of
sodium channel blockade forms the basis of the provocation test and explains the increased
prevalence of mutations in the gene (SCN5A) encoding the cardiac sodium channel in the
population with Brugada syndrome [25]. Conduction block at branching points delays
local activation, causes fractionation in local unipolar electrograms [26], and may set the
stage for reentrant arrhythmias (Figure 1C). Indeed, fractionated local electrograms have
been recorded from patients with Brugada syndrome, although the duration of these
fractionations does not cover the entire phase of ST-elevation [9–11]. The explanation
for this apparent discrepancy is that the tissue beyond the tissue branching points is
not activated at all (excitation failure) while being excitable and coupled to the proximal
tissue. As a consequence, a potential difference occurs between the unexcited and adjacent
activated tissue and generates a systolic current that is visible in the ECG as ST-segment
elevation [12]. Fractionated potentials as a reflection of late activation thus occur merely at
the end of the QRS complex and do not necessarily have to extend throughout the duration
of the ST elevation.
In Brugada syndrome, arrhythmias are initiated predominantly in the RVOT [27]. In
2013, we have proposed that the intrinsic conduction reserve in the RVOT is lower than
in the remainder of the heart because of its developmental origin, which would facilitate
conduction delay and block in the presence of structural abnormalities [28,29]. The RVOT
is often the source of arrhythmias, and the initiating premature activation can be the result
of the arrhythmogenic substrate as described above [21].
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Figure 1. Abnormal conduction in the right ventricular outflow tract (RVOT) as explanation for the Brugada syndrome. (A).
The structural abnormalities (yellow) in the RVOT separate activation fronts causing fractionated unipolar electrograms.
(B). The abnormalities may also set the stage for current-to-load mismatch leaving part of the myocardium unexcited. This
myocardium acts as a current sink during systole and receives current from adjacent—excited—tissue causing unipolar
electrograms with ST segment el vation (J-point). (C) Current-to-load mismatch may also gen rate unidirectional block and
the onset of reentry. The lighter shade of purple in the RVOT indicat s a lowe c nduction reserve resulting from a distinct
embryonic origin [28]. RVOT, right ventricular outflow tract; RV, right ventricle; Endo, endocardium; Epi, epicardium.
3. Overlap in Mechanism of Brugada Syndrome and Early Repolarization Syndrome
3.1. Structural Abnormalities and Fractionated Potentials
Structural abnormalities have been reported repeatedly in Brugada syndrome pa-
tients [8,10,17,19]. Fibrosis is found in both the subendocardium [30] and subepicardium [10].
Whether fibrosis in Brugada syndrome patients is more prominent in the RVOT than in
the remainder of the heart has not yet been thoroughly investigated. However, it has
become clear that hearts from Brugada syndrome patients are histologically different from
controls [31]. This suggests that the Brugada syndrome is a structural disease rather than a
channelopathy [15]. In the ECG of patients with a structural heart disease, e.g., arrhythmo-
genic ventricular cardiomyopathy, Chagas disease, or Uhl’s disease, slurring or notching at
the end of the QRS complex is often present and is referred to as the early repolarization
pattern [32,33]. The early repolarization pattern is also present in the ECG of some Brugada
syndrome patients [34]. Patients with the early repolarization pattern and with ventricular
arrhythmias who, after standard clinical evaluation, appear to have a structurally normal
heart are diagnosed with early repolarization syndrome [1]. However, epicardial mapping
of these patients often reveals sites with fractionated electrograms [34,35], which are indica-
tive of a structural substrate [26]. Ablation of these sites prevents ventricular fibrillation,
indicating that these regions are required for arrhythmogenesis [9].
We recently reported the first case of early repolarization syndrome in which localized
fibrosis in the right ventricular inferior wall caused ventricular fibrillation and the early
repolarization pattern in the ECG [16]. Echocardiography and magnetic resonance imaging
(MRI) did not reveal gross structural abnormalities in this p tient. This le ves room for
the possibility that other patients with the early repol rizati n syndrome ave structural
abnormalities as well, which have remained undetected so far. Currently, echocardio-
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graphy, computed tomography, and MRI are used to assess structural and functional
abnormalities in patients suspected of structural heart disease [15]. These techniques are
presently not sensitive enough to detect transmural fibrosis in Brugada syndrome patients
(and also not in the patient with early repolarization syndrome) [8,16]. A biopsy of the
myocardium would allow detection of transmural fibrosis by conventional histology us-
ing a Picro-Sirius-red or Masson’s trichrome staining. Electroanatomic voltage mapping
could designate the location for tissue sampling by identifying regions with low-amplitude
fractionated potentials [36]. Establishing the causal relation between transmural fibrosis
and fractionated potentials in patients with the early repolarization syndrome will fos-
ter radiofrequency ablation as a future antiarrhythmic therapy in patients with the early
repolarization syndrome [37].
3.2. J-Waves in Local Electrograms and Excitation Failure
Late activation appears to be associated with pronounced local J-waves because
the notch in the local epicardial action potential in late activated tissue is exposed in
the ST segment [16,37,38]. This type of electrogram shows large R-waves—indicating
late activated myocardium—followed by a positive J-wave as seen in Figure 2A (upper
panel). These morphological features are often observed in local electrograms in early
repolarization syndrome patients [16,38]. Similar J-waves that follow an R-wave (in a
unipolar electrogram) can be found in Brugada syndrome patients as well, although they
are often described following an S-wave [11,34]. Such J-waves may appear in tissue
undergoing excitation failure caused by current-to-load mismatch whereby fractionated
potentials precede a monophasic potential, imposing as ST elevation in the extracellular
electrograms [21,39].
Excitation failure in early repolarization syndrome may manifest also in a different
manner. Figure 2A shows a simulated electrogram from late-activated subepicardium of
the right ventricular free wall before and after excitation failure (gray squares represent
tissue with excitation failure). A notching of the QRS complex was seen, although the
J-wave disappeared when excitation failure occurred. The same configuration was recorded
from the right ventricular wall of a heart of a patient with early repolarization syndrome
(Figure 2B). We speculate that in the patients at this location, excitation failure occurred
leading to this electrogram morphology.
3.3. Generation of the J-Wave in the Electrocardiogram through Structural Abnormalities
If the compromised tissue—distal to the isthmus where excitation failure occurred—is
located at the end of the normal activation pathway, it will not be activated at all, even
though this tissue is excitable. The RVOT is normally the last part of the heart to be activated.
As a consequence, a large systolic intracellular electrotonic “injury” current will flow from
the activated tissue towards the unexcited tissue (located in the RVOT) and will generate
a monophasic extracellular potential [11,39]. This potential will also be represented on
the right precordial leads (or leads placed more cranially) of the ECG in the form of ST-
elevation typical for Brugada syndrome [12]. However, if the compromised tissue is located
in myocardium that is activated relatively late in the QRS complex but not at the very end
of the normal activation pathway (not in the RVOT, but in the LV free wall or RV free wall),
the initially unexcited tissue will be activated with a delay through a secondary activation
route. As a consequence, a short-lasting systolic intracellular electrotonic current will flow
from the activated tissue towards the unexcited tissue that will generate a short-lived
positive extracellular potential. This potential will be represented on the according leads of
the ECG as a fractionated QRS complex or J-wave in the ECG. This constitutes the typical
early repolarization pattern.
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Figure 2. Local J-wave and excitation failure in relation to the early repolarization syndrome. (A).
Simulated activation maps and extracellular potentials during sodium channel reduction (30%)
in the absence (upper) and presence (lower) of structural abnormalities. Propagation and extra-
cellular potential were simulated using a similar approach as published previously [12]. In brief,
pro agating action potentials (AP) were simulated with monodoma n reaction-diffusion equation,
using software tha has be de cribed previously [40]. Ionic currents were computed with the Ten
Tusscher-Noble-Noble-Panfilov model for the human ventricular myocyte [41], which distinguishes
subendocardial, mid-myocardial, and subepicardial cell types. Computation of extracellular poten-
tials (electrograms) from the simulated membrane potentials was based on the bidomain model for
cardiac tissue [42]. Delayed activation in location a resulted in a pronounced J-wave in the corre-
sponding local electrograms. In the presence of structural abnormalities excitation failure occurred
and the local J-wave disappeared. Panel (B) shows the epicardial activation pattern at the right
inferior wall measured during open chest mapping [16]. The delayed activated myocardium (in blue)
showed nipolar electrograms with (c) nd it out (d) a local J-wave. We speculate that excitation
failure occurred at location d. ERP, early repolarization pattern.
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3.4. Paradoxical Effect of Sodium Channel Blockade
Sodium channel blockade augments ST elevation in the Brugada syndrome but tends
to suppress QRS slurring in the early repolarization syndrome. This paradox could hint
towards a separate mechanisms giving rise to the ECG abnormalities in the different
syndromes. However, this difference is likely related to the availability of alternative
activation routes to the myocardium distal to the conduction block created by sodium
channel blockade. In Brugada syndrome, such an alternative route is largely absent in the
RVOT and the distal myocardium is, therefore, not excited, although it is excitable [21]. This
creates the characteristic prolonged ST-elevation generated by coupling excited tissue to
unexcited tissue (similar to the genesis of a monophasic action potential) [43]. In the heart
with an early repolarization pattern, the structural abnormality is positioned in the free wall
of the left or right ventricle, where alternative activation routes to the blocked myocardium
are present. The sodium channel blockade, in this case, transforms the delayed activation
into activation block. In addition, because the myocardium is not the terminally activated
tissue, ajmaline-induced conduction slowing in the rest of the heart may delay activation
in the rest of the heart beyond that of the structurally altered tissue. Experimental evidence
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Figure 3. Inferolateral J waves and their attenuation by sodium channel blockers. The effects of reduced Na current, reduced
coupling, and increased transient outward current on inferolateral J waves were evaluated with computer simulations using
a detailed model of the human heart and torso [44]. Propagating action potentials were simulated with a monodomain
reaction-diffusion model. At 1-ms intervals the simulated transmembrane currents were inserted in a torso model and a
static bidomain problem was solved to obtain the electrocardiogram (ECG). Global reduction in Na-channel conductivity
deformed and prolonged the QRS complex, masking the inferolateral J-waves. Subtraction of the ECGs with and without
local intervention showed that the ECG change associated with the local reduction in Na current was not reduced, but was
only hidden by the expanding QRS complex.
4. Temporal Variability in Signs and Symptoms in Both Syndromes
Patients with Brugada syndrome or with the early repolarization syndrome do not
always show the characteristic signs pertaining to the respective syndromes. The typical
ST-T changes of Brugada syndrome are not always present and may only be observed after
provocation with an intravenous sodium channel blocker (Ajmaline) or after a full-stomach
test [45]. Even without provocative maneuvers, the symptoms and signs may wax and
wane [46]. Similarly, the electrocardiographic changes belonging to the early repolarization
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pattern are unstable [1] and are modulated by exercise and sodium channel blockade. Small
alterations in conduction reserve over time could explain the wax and wane of symptoms.
The reduction in conduction reserve at the site of source-sink mismatch can be mod-
ulated by various ionic currents other than the sodium current (INa) [47]. An increase
in the density of the transient outward current (ITO) or a decrease in that of the calcium
current (ICaL) will reduce conduction reserve and hamper conduction across the site of
tissue expansion and will exacerbate the conduction abnormality and the consequent ST
elevation [21]. The densities of these currents fluctuate under influence of, e.g., heart rate,
autonomic nervous system, diet, and circadian rhythm.
Drugs and compounds other than class I drugs have sodium channel blocker prop-
erties. For example, dietary fish oil consumption leads to sodium channel inhibition [48].
A meal containing fatty fish, therefore, may reduce conduction reserve [49] and provoke
the Brugada sign. We speculate that this contributes to the full stomach effect that has
been used as a provocation test for the Brugada sign [45]. Certainly, the postprandial
parasympathetic surge may also be of importance.
But even without the use of sodium-channel blockers, the sodium channel can have
reduced function. The upstroke velocity of the cardiac action potential depends on the
resting membrane potential and therefore on the coupling interval between the premature
activation and the previous activation. If the premature activation encroaches on the
repolarization phase of the previous activation, the take-off potential of the premature beat
is less negative, and subsequently fewer ion channels are available. However, if this is
related to an increased sympathetic drive the influence of the calcium channel kicks in with
contrary effects [50].
Hoogendijk et al. have shown in a computer model of a heart with structural abnor-
malities that a decrease in ICaL also is capable of provoking the Brugada sign [21]. This
effect is based on the observation that in structurally altered myocardium, the potential
difference between activated and non-activated tissue may be maintained by the plateau of
the action potential [51], if phase 0 has passed, and may even lead to propagation across a
region of impaired conduction. Conversely, a temporary decreased calcium current (use of
calcium channel blocking drugs and decreased sympathetic tone) may provoke activation
block, if structural abnormalities are present.
The simulations by Potse et al. [21] have also demonstrated the modulatory effect of the
transient outward current. If ITO is increased, conduction across a branching structure may
be hampered [51], and thus may lead to the Brugada sign. Typical circumstances in which
the ITO is increased are a slow heart rate (during sleep, increased parasympathetic tone).
Conversely, inhibition of ITO may exert an antiarrhythmic effect or decrease the Brugada
sign. Because ITO is particularly highly expressed in the subepicardial myocardium [52],
the effects of ITO-modulation are expected particularly in the subepicardium.
5. Conclusions and Future Perspectives
Brugada syndrome is primarily caused by subtle, clinically undetectable, structural
abnormalities in the RV and RVOT [15] and therefore should be considered as a cardiomy-
opathy. We speculate that at least a subgroup of the patients with the Early Repolarization
Syndrome also display similar subtle structural myocardial abnormalities in regions other
than the RVOT [16]. The common electrophysiological mechanism is formed by conduction
abnormalities, caused by current-to-load mismatch. The modulatory effects of sodium
channel inhibition and arrhythmogenesis can be explained by the same mechanism [10].
Although we cannot exclude the possibility that some of the patients with early repolar-
ization syndrome have repolarization abnormalities (independent of altered conduction)
the definition of J-wave syndromes should not include the criterion of absence of struc-
tural abnormalities [1]. The inability to detect these localized structural changes in the
clinic is the reason that patients with a J-wave syndrome are thought to have structurally
normal hearts [53]. Figure 4 shows the relation between the detection method and the
diagnosis of various syndromes. We expect that with the increasing extent of the structural
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abnormalities (by ageing, comorbidities, or possibly by previous cardiac surgery), the
J-wave syndromes will eventually become incorporated in the spectrum of structural heart
diseases [15]. Similarly, with the expected increasing resolution of the imaging techniques,
we expect that the same patients that are now diagnosed with one of the J-wave syndromes
will be diagnosed with structural heart disease in the near future. The latter is relevant
for patient management as a structural origin of arrhythmias provides a rationale for
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Figure 4. The definition of structural heart disease is based on the ability to detect structural abnormalities. An increased
spatial resolution of the detection technique will lead to a leftward shift of the red zone. ERP, early repolarization pattern;
BrS, Brugada syndrome; ARVC, arrhythmogenic right ventricular cardiomyopathy; Uhl’s, Uhl’s disease; MRI, magnetic
resonance imaging; Echo, echocardiography. This figure was used with permission from [54].
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